Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

A joint team of researchers from POSTECH and Georgia Institute of Technology successfully created an engineered heart via 3D printing technology that allows for early monitoring of drug-induced cardiotoxicity
News | Medical 3-D Printing
In Vitro 3D Engineered Heart Tissue that Monitors Drug-induced Cardiotoxicity

March 29, 2023 — Cardiotoxicity is a clinical condition that arises from using pharmaceutical agents such as antibiotics ...

Home March 29, 2023
Home
People exposed to low doses of ionizing radiation have an extra, but modest, risk of developing heart disease during their lifetime, according to a new study
News | Heart Failure
Low-dose Radiation Linked to Heart Disease

March 28, 2023 — People exposed to low doses of ionizing radiation have an extra, but modest, risk of developing heart ...

Home March 28, 2023
Home
PH-HFpEF affects more than 1,600,000 North Americans, with estimates indicating a prevalence of more than 2,000,000 patients by 2030
News | Cardiovascular Clinical Studies
Tenax Announces Issuance of U.S. Patent Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

March 27, 2023 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and ...

Home March 27, 2023
Home
The recalled product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
News | Antiplatelet and Anticoagulation Therapies
Ascend Laboratories Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules Due to the Detection of NDMA Impurity

March 24, 2023 — According to the U.S. Food and Drug Administration (FDA), Ascend Laboratories LLC is voluntarily ...

Home March 24, 2023
Home
CardioMEMS is a tiny implantable sensor that can remotely flag early warning signs of worsening heart failure
News | Heart Failure
New Data Show Remote Monitoring Technology Like Abbott’s Cardiomems Helps Improve Survival in Heart Failure Patients

March 24, 2023 — Abbott announced new data that found monitoring patients remotely with hemodynamic pressure sensing ...

Home March 24, 2023
Home
A newly-published study in the European Society of Cardiology’s European Heart Journal is shedding new light on the obesity paradox.
News | ESC
Study Puts ‘Obesity Paradox’ in Spotlight: Waist-to-height Ratio Better Than BMI as Indicator of Outcomes in Patients with Heart Failure

March 23, 2023 — Newly-published research has debunked the idea that there is an “obesity paradox,” whereby patients ...

Home March 23, 2023
Home
News | Cardiovascular Clinical Studies
Clinical Science Session at THT 2023 Presents 12-month Data on AccuCinch Ventricular Restoration System for Heart Failure Patients with HFrEf

March 22, 2023 — Ancora Heart, Inc., a privately-held Santa Clara, CA-based company developing a completely ...

Home March 22, 2023
Home
Late-breaking data presented at THT shows substantial fluid loss and improvements in kidney and cardiac function at 30 days after Aortix therapy
News | Heart Failure
Aortix Pump Therapy Leads to Rapid Decongestion and Improved Kidney Function in Hospitalized Patients with Heart Failure and Worsening Renal Function

March 21, 2023 —  Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac ...

Home March 21, 2023
Home
The full results of BeAT-HF, including a number of additional analyses and endpoints, will be submitted by the executive steering committee for publication in one or more peer-reviewed journals
News | Heart Failure
Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure

March 21, 2023 — CVRx, Inc., a commercial-stage medical device company focused on developing, manufacturing and ...

Home March 21, 2023
Home
The first platform to combine real-world cardiology data from millions of people in multiple European countries is set to advance research aimed at improving heart health
News | Cardiovascular Clinical Studies
New European Heart Disease Data Set to Advance Research Aimed at Improving Heart Healt

March 21, 2023 — The first platform to combine real-world cardiology data from millions of people in multiple European ...

Home March 21, 2023
Home
More donated hearts could be suitable for transplantation if they are kept functioning within the body for a short time following the death of the donor, new research has concluded.
News | Artificial Heart
Maintaining Heart Function in Donors Declared ‘Dead by Circulatory Criteria’ Could Improve Access to Heart Transplantation

March 17, 2023 — More donated hearts could be suitable for transplantation if they are kept functioning within the body ...

Home March 17, 2023
Home
News | ESC
EHRA 2023 Offers the Latest Science in Heart Rhythm Disorders

March 17, 2023 — Discover what’s new and on the horizon in the prevention and treatment of heart rhythm disorders at EHR ...

Home March 17, 2023
Home
Many patients don’t receive much rehabilitation therapy following a stroke, despite strong evidence that higher amounts can reduce long-term disability, according to a new UCLA-led study that tracked over 500 patients across 28 acute care hospitals in their first year following a stroke.
News | Stroke
Many Patients Receive Too Little Rehab Therapy Following Stroke, Study Finds

March 15, 2023 — Many patients don’t receive much rehabilitation therapy following a stroke, despite strong evidence ...

Home March 15, 2023
Home
Results Suggest CardiAMP Cell Therapy May Have Ability to Restore and Maintain Heart Function to Previously Non-Functioning Areas of the Heart Up to Two Years After Treatment
News | Cardiovascular Clinical Studies
Positive Echocardiography Data from BioCardia Phase III CardiAMP Cell Therapy Heart Failure Trial Presented at American College of Cardiology Annual Meeting

March 13, 2023 —  BioCardia, Inc., developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2023
Home
The first evidence that exceeding the World Health Organization (WHO) ozone limit is associated with substantial increases in hospital admissions for heart attack, heart failure and stroke
News | ESC
Ozone Pollution is Linked with Increased Hospitalizations for Cardiovascular Disease

March 10, 2023 — The first evidence that exceeding the World Health Organization (WHO) ozone limit is associated with ...

Home March 11, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now